Policies & RegulationsPharmacyHospitalsPharma & DistributionDrug ApprovalsIP IssuesDomestic NDD
  news bulletin  
Generic names in trade names may work
by Eui Kyoung Yoon (ekyeun@dreamdrug.com)
Published : Jan 3, 2014 11:54:21
Researchers in National Health Insurance Service (NHIS) suggested that pharmaceutical companies should include generic names in trade names or doctors should include generic names on written prescriptions to encourage the use of generic drugs.

According to the NHIS’s latest study, generic names should be recognized on the prescriptions to affect doctors’ and patients’ behavior, adding that price cuts themselves don’t work well.

The study mentioned that generic names are used for trade names in overseas countries and patients in those countries can get drug information simply by looking at trade names for generic versions.

It also suggested incentives for generic substitution help the government reduce healthcare spending and pharmacy’s notices to doctors after generic substitution could be made by utilizing the current drug utilization review system.

It added that rebates should be eradicated and the government should have consumers feel the actual cost of prescription drugs.
Reply 0
Name Password
Popular News
Champix to be covered, starting Feb 2015
First generic version of Omacor approved
OTC drugs will be available at some resorts
Novartis Korea and KPWA agreed on margin increase
MSD’s new COX-2 inhibitor Arcoxia approved
All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted,
displayed, published or broadcast without the prior consent of dailypharm.com